<i>In Vivo</i> Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
Marguerite L. Monogue(Hartford Hospital), David P. Nicolau(Hartford Hospital), Sara Giovagnoli(Hartford Hospital), Claudia Zampaloni(Roche (Switzerland)), Caterina Bissantz(Roche (Switzerland))
Cited by 55
Related Papers
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria
|Intensive Care Medicine|2015|182
A Real-World Perspective on Molecular Design
|Journal of Medicinal Chemistry|2016|120